ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Clinical trial NCT04245085 · COMPLETED

Trial details

NCT number: NCT04245085
Sponsor: ETOP IBCSG Partners Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC

Start date: 2020-09-29
Primary completion: 2024-07-22
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.